SCA
AMYT

Stonebridge Capital Advisors’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Stonebridge Capital Advisors’s Portfolio AMYT Stock Details AMYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5
Closed -$37 – 1150
2022
Q2 		$0 Hold
5
– – ﹤0.01% 1111
2022
Q1 		$0 Sell
5
-17
-77% -$153 ﹤0.01% 1124
2021
Q4 		$0 Buy
+22
New +$238 ﹤0.01% 1078

Other funds holding AMYT

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Stonebridge Capital Advisors's AMYT Position: Q3 2022 in Review

Stonebridge Capital Advisors sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q3 2022, closing a stake of 5 shares — an estimated $37 sold.

Stonebridge Capital Advisors first reported a position in AMYT in Q4 2021 and held it in 3 quarters. The position peaked at $0 in Q2 2022. 62 funds tracked by Wall St. Rank hold AMYT as of Q3 2022.

  • Stonebridge Capital Advisors reported no remaining Amryt Pharma plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 5 Amryt Pharma plc American Depositary Shares shares in Q3 2022, an estimated $37.
  • Stonebridge Capital Advisors first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • Stonebridge Capital Advisors's Amryt Pharma plc American Depositary Shares position peaked at $0 in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q3 2022.

Based on Stonebridge Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.